Biblio Discovery — Demo Discovery Service

9 results for "Epameinondas Koumpis"

Showing 1–9 · 1.03 seconds · RSS

  1. Journal Article Full text

    Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia

    Georgios Petros Barakos; Vasileios Georgoulis; Epameinondas Koumpis et al.

    Diseases, Vol. 13 No. 1 · 2025 · English · DOAJ Scopus

    T cells, as integral components of the adaptive immune system, recognize diverse antigens through unique T cell receptors (TCRs). To achieve this, during T cell maturation, the thymus generates a wide repertoire of TCRs. This is essential for understanding cancer evolution, progression, and the…

  2. Journal Article Full text

    Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis

    Eleftheria Hatzimichael; Despoina Timotheatou; Epameinondas Koumpis et al.

    Diseases, Vol. 10 No. 4 · 2022 · English · DOAJ Scopus

    Anemia is a common feature of both benign and malignant hematologic diseases. Beta-thalassemia (β-thalassemia) syndromes are a group of hereditary disorders characterized by ineffective erythropoiesis, due to a genetic deficiency in the synthesis of the beta chains of hemoglobin, often accompanied…

  3. Journal Article Full text

    Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study

    Alexandra Papoudou-Bai; Epameinondas Koumpis; Georgia Karpathiou et al.

    Diseases, Vol. 12 No. 3 · 2024 · English · DOAJ Scopus

    GATA3 is a transcription factor involved in T-cell maturation and has been previously shown to be aberrantly overexpressed in malignant Hodgkin and Reed–Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL). However, the immunophenotypes of the cell types expressing GATA3 have not been…

  4. Journal Article Full text

    Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications

    Epameinondas Koumpis; Alexandra Papoudou-Bai; Konstantina Papathanasiou et al.

    Current Issues in Molecular Biology, Vol. 46 No. 7 · 2024 · English · DOAJ Scopus

    Diffuse large B cell lymphoma (DLBCL) is a multifaceted condition characterized by significant diversity in its molecular and pathological subtypes and clinical manifestation. Despite the progress made in the treatment of DLBCL through the development of novel drugs, an estimated one-third of…

  5. Journal Article

    Rifampicin-Induced Thrombocytopenia: A Case Report and Short Review of the Literature

    Epameinondas Koumpis; Konstantina Papathanasiou; Ioannis Papakonstantinou et al.

    European Medical Journal (2021) · 2021 · English · DOAJ

    Thrombocytopenia may be associated with a variety of conditions and risks depending on its severity, ranging from mild epistaxis to life-threating bleeding. Many drugs or herbal remedies can cause thrombocytopenia by either inhibiting platelet production and/or enhancing their destruction from the…

  6. Journal Article Full text

    The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

    Epameinondas Koumpis; Vasileios Georgoulis; Konstantina Papathanasiou et al.

    Biomedicines, Vol. 12 No. 12 · 2024 · English · DOAJ Scopus

    Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL). Despite the use of newer agents, such as polatuzumab vedotin, more than one-third of patients have ultimately relapsed or experienced refractory disease. MiRNAs are single-stranded, ~22-nucleotide-long…

  7. Journal Article Full text

    Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis, and Monitoring of Multiple Myeloma Patients

    Dimitrios Leonardos; Leonidas Benetatos; Elisavet Apostolidou et al.

    Diseases, Vol. 13 No. 10 · 2025 · English · DOAJ Scopus

    Multiple myeloma (MM) is one of the most common hematological malignancies and remains incurable. However, the survival of multiple myeloma patients has significantly increased due to the implementation of novel therapies along with autologous stem cell transplantation, changing the natural history…

  8. Journal Article Full text

    The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell Lymphoma

    Eirini Panteli; Epameinondas Koumpis; Vasileios Georgoulis et al.

    Non-Coding RNA, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Diffuse large B-cell lymphoma (DLBCL) is the most common and clinically aggressive subtype of non-Hodgkin lymphoma (NHL). While novel therapies such as rituximab and polatuzumab vedotin have led to improved outcomes, approximately 35% of patients eventually develop relapsed or refractory disease…

  9. Journal Article Full text

    The Spectrum of Human Herpesvirus 8/Epstein–Barr Virus-Co-Positive Lymphoproliferations and Lymphomas

    Epameinondas Koumpis; Maria Nasiou; Georgios Monastiriotis et al.

    Diseases, Vol. 14 No. 9 · 2026 · English · DOAJ Scopus

    Background/Objectives: Human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV), is a gamma-2 herpesvirus implicated in a distinctive group of lymphoproliferative disorders (LPDs) and lymphomas. In some of these entities, lesional cells are concurrently infected with…